Docosahexaenoic Acid (DHA) Market Analysis by Type (Fish Oil DHA, Algae DHA, and Others); by Form (Powder, and Liquid); by Application (Improving Memory, Brain Development, and Others); and by End-User (Breastfeeding Mothers, Infants, Pregnant Mothers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Buy Now Report ID: 3946 | Published Date: Mar 24, 2023
The global docosahexaenoic acid (DHA) market is estimated to garner a revenue of ~USD 13 Billion by the end of 2035 by growing at a CAGR of ~11% over the forecast period, i.e., 2023 – 2035. Further, the market garnered revenue of ~USD 4 Billion in the year 2022. The growth of the market can be attributed to the worldwide escalating ratio of health-conscious people. Based on a survey, at present time, approximately 65% of people throughout the world are health-conscious and are concerned to maintain a healthy lifestyle. Besides this, the increasing awareness among people regarding the numerous health benefits of DHA is also projected to proliferate the market growth further throughout the projected time frame.
In addition to these, factors that are believed to fuel the growth of the global docosahexaenoic acid (DHA) market include the increasing intake of dietary supplements by people to keep a balance of multivitamins, and minerals in their diet. For instance, in developed countries, between 42% to 58% of individuals are taking dietary supplements. Moreover, DHA delivers numerous health benefits and reduces the risk of certain disorders comprising vision loss, cardiovascular disorders, and so on. Hence, this factor is also projected to majorly boost market growth over the projected time frame.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~11% |
|
Base Year Market Size (2022) |
~ USD 4 Billion |
|
Forecast Year Market Size (2035) |
~ USD 13 Billion |
|
Regional Scope |
|
Growth Drivers
Escalating Cases of Depression - Depression is a widespread and dangerous medical condition that alters a person’s mood. It is associated with feelings of despair and loss of interest in activities. Lack of docosahexaenoic acid (DHA) is one such cause that triggers depression in a person. Dosage of EPA and DHA Omega-3s is linked to a considerable reduction in depressive symptoms. Thus, the surge in cases of depression throughout the world is anticipated to drive market growth in the coming years. As reported in the World Health Organization (WHO) 2021 report, depression affected an estimated 5% of individuals globally.
Worldwide Surging Risk of Preterm Births - Preterm birth occurs when a baby is born prematurely, before the 37th week of pregnancy. The risk of death or major disability increases with the preterm birth of a baby. For instance, By the end of 2020, over 16 million preterm births occurred globally, resulting in an 11% preterm birth rate worldwide. Along with this, premature birth is the main cause of mortality in children, responsible for up to 37% of infant deaths and nearly 19% of all deaths in children under the age of 5 years. DHA helps in reducing the risk of preterm birth by providing essential nutrients to the fetus. Hence, the surging risk of preterm births is also estimated to spur market growth in the coming years.
Increase in Unhealthy Eating Habits - Unhealthy eating practices encompass undereating or overeating, not getting enough of the essential nutrients we need every day, or taking an excessive amount of low-fiber, high-fat, and sugar-containing foods and beverages. Such kind of food items deliver more harm to our overall health and even increases the death toll. The surge in unhealthy eating habits has been increasing the tendency to consume DHA-enriched supplements to get the required amount of essential nutrients for overall health, which is projected to fuel market growth. According to a global report, in 2021, nearly 49% of people ate either too little or too much.
Growing Incidences of Cardiovascular Disorders - Cardiovascular disease refers to a set of disorders that damage the blood vessels and arteries. These conditions can affect one or more parts of the heart or blood arteries. Cardiovascular disorders are the leading cause of death throughout the world. DHA has been proven in various studies to play a vital role in the functionality of vascular endothelial cells. DHA can minimize endothelial dysfunction and prevent CVD through effects on endothelium metabolism, inflammation, thrombosis, and arrhythmia when consumed regularly with n-3 PUFAs. Hence, this factor is anticipated to drive the market growth in the coming years. According to the World Health Organization, with 17.9 million deaths per year, cardiovascular disorders are the most common cause of mortality worldwide.
Rising Disposable Income – Based on Bureau of Economic Analysis data, by March 2022, personal income and disposable personal income (DPI) in the United States climbed by USD 107.2 billion and USD 89.7 billion, respectively.
Challenges
The global docosahexaenoic acid (DHA) market is segmented and analyzed for demand and supply by type into fish oil DHA, algae DHA, and others. Out of these three types of segments, the algae DHA segment is estimated to gain the largest market share of about ~61% in the year 2035. The growth of the segment can be attributed to the surging production of algae DHA for therapeutic applications, followed by the rising application of algae-based omega-3s in infant food. For instance, worldwide algae output (combined production and wild collection) expanded more than 60 times, from 0.55 million (wet) tons in 1950 to 36.84 million tons in 2019. Additionally, omega ingredients derived from algae are considered to be more bioavailable and environmentally friendly to produce. This, as a result, is estimated to further boost the segment growth in the projected time frame.
The global docosahexaenoic acid (DHA) market is also segmented and analyzed for demand and supply by end-user into breastfeeding mothers, infants, pregnant mothers, and others. Amongst these four segments, the pregnant mothers segment is expected to garner a significant share of around ~50% in the year 2035. The growth of the segment can be majorly attributed to the increasing awareness in parents regarding the better development of their infant, coupled with the rising awareness regarding preterm birth and its complexities. In addition to this, the enhanced availability of better health facilities for pregnant women across the globe, which anticipated to spur the segment growth in the coming years.
Our in-depth analysis of the global docosahexaenoic acid (DHA) market includes the following segments:
|
By Type |
|
|
By Form |
|
|
By Application |
|
|
By End-User |
|
The Asia Pacific docosahexaenoic acid (DHA) market, amongst the market in all the other regions, is projected to hold the largest market share of about ~42% by the end of 2035. The growth of the market can be attributed majorly on the back of increasing awareness regarding health amongst people, along with improving healthcare facilities in the region. Moreover, the growing healthcare expenditure in the APAC region is estimated to play a major role in the market growth. According to the World Bank data, healthcare expenditure per capita of population in the South Asia reached USD 1,959.342 in 2019. As of the surging urbanization, the lifestyle of people has been significantly changing across the region, this, as a factor, is estimated to drive the market growth further throughout the forecast period in the region.
The North American docosahexaenoic acid (DHA) market, amongst the market in all the other regions, is projected to hold the second largest share of about ~30% during the forecast period. The growth of the market can be attributed majorly to the increasing healthcare awareness among people, especially regarding brain development in the prenatal stage. Furthermore, high awareness amongst people regarding diseases, such as dementia, is estimated to boost market growth. In addition, the expanding consumption of several kinds of immune health supplements, along with the surging numbers of consumers who have been opting for concentrated dietary supplements to address their nutritional needs for DHA are also projected to boost market growth further throughout the forecast period in the region.
Further, the market in the European region, amongst the market in all the other regions, is projected to hold a majority of the share of about ~15% by the end of 2035. The growth of the market can be attributed majorly to the increasing awareness among people regarding dietary nutrition which is required for good health, coupled with the escalating support of the government to promote the intake of DHA daily. In addition to this, the expanding risk of cardiovascular disorders and rising awareness in people about these disorders is also a major factor that is anticipated to accelerate the growth of the docosahexaenoic acid (DHA) market in the European region in throughout the forecast period.
Koninklijke DSM N.V. announced the release of its novel, high-quality life'sDHA SF55-O200DS oil for maternal and early-life nutritional solutions. This new plant-based high-potency DHA oil strengthens the company's maternal and baby nutrition range.
Croda International Plc acquired Solus Biotech from Solus Advanced Materials, which is a prominent provider of high-end, biotechnology-derived beauty activities.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Anil Kumar, Ipsheeta Dash
Ans: Escalating cases of depression, increase in unhealthy eating habits, and worldwide surging risk of preterm births are the major factors driving the market growth.
Ans: The market is anticipated to attain a CAGR of ~11% over the forecast period, i.e., 2023 – 2035.
Ans: Associated side effects of docosahexaenoic acid (DHA), unstable supply of raw materials, high cost of concentrated DHA are estimated to be the growth hindering factors for the market expansion.
Ans: The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by type, form, application, end-user, and by region.
Ans: The algae DHA segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
